SARAH BOBBITT: Open Payments
NPI 1922643774 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 54 payments from 14 companies in 2025. Trend: 2023 $1,234 · 2024 $709 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $198 |
| ABBVIE INC. | 16 | $171 |
| AstraZeneca Pharmaceuticals LP | 8 | $154 |
| SANOFI-AVENTIS U.S. LLC | 3 | $57 |
| Lilly USA, LLC | 2 | $46 |
| PFIZER INC. | 3 | $45 |
| Inspire Medical Systems, Inc. | 2 | $41 |
| Dexcom, Inc. | 2 | $36 |
| Medtronic, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
Products named: AIRSUPRA, QULIPTA, Wegovy, UBRELVY, TZIELD, ELIQUIS, Ozempic, INSPIRE.
Industry payments across TX — which companies pay providers there.
